跳至主要内容
临床试验/IRCT20100524004010N36
IRCT20100524004010N36招募中2 期

Evaluation of the Combined Effects of Flaxseed Consumption and Fasting Mimicking Diet (FMD) on Anthropometric Indices, Blood Lipid Composition, Glycemic Control, Inflammatory Markers, Steatosis and Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver Diseases (NAFLD): a Randomized Control Trial

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age over 18 years
  • Having evidence of non-alcoholic steatohepatitis and CAP score over 263
  • Not having a history of alcohol and drug abuse
  • Absence of other chronic and acute liver disorders
  • No use of chemical and herbal medicines that affect the liver and weight
  • Not having a chronic inflammatory disease and no history of cancer
  • No treatment with anti-inflammatory drugs, corticosteroids and hormones
  • Not having lost more than 8 percent of the weight in the last 6 months
  • Blood pressure less than 140/90 mmHg
  • Not having uncontrolled kidney disease, pituitary disorders, thyroid, cardiovascular diseases, diabetes and digestive system disorders that affect absorption
  • No history of excessive consumption of flaxseed
  • Not having clinically diagnosed psychiatric disorders that impair the patient's ability to provide written informed consent
  • Willingness to participate in the study

排除标准

  • Having clinically diagnosed psychiatric disorders that impair the patient's ability to provide written informed consent
  • Use of other supplements
  • Unwillingness to participate in the study

研究者

相似试验

Evaluation of the Combined Effects of Flaxseed... | 临床试验